Cart
0

Implantable Cardiac Monitors Market by Indication (Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls) and End User (Hospitals, Cardiac Centers & Clinics and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_174517
Pages: 207
Dec 2017 | 1689 Views
 
Author's : Suraj Sajeev & Garima Chandra
Tables: 83
Charts: 45
 

Implantable Cardiac Monitors Market Overview:

Implantable Cardiac Monitors Market was valued at $410.4 million in 2016, and is expected to reach at $678.3 million by 2023, registering a CAGR of 7.4% from 2017 to 2023. The implantable cardiac monitor, also referred to as implantable loop recorder, is a small insertable device that continuously monitors hearth rhythms. These monitors are considered as the gold standard for evaluating the infrequent and unexplained arrhythmias.

The major factor that drives the market growth is the longevity of implantable cardiac monitors. In addition, implanting a cardiac monitor requires less duration, hence less hospital stay and fewer hospital readmission are required. However, the availability of alternative mode of treatments and the high cost of implantable cardiac monitors is set to hamper the growth of this market. Moreover, the increase in awareness about devices and treatment options for cardiac disorders will create lucrative opportunities for the key players in this market.

The global implantable cardiac monitors market is segmented based on indication, end user, and region. On the basis of indication, the market is divided into cardiac arrhythmias, atrial fibrillation, and epilepsy & unexplained falls. By end user, it is classified into hospitals, cardiac centers & clinics and ambulatory surgical centers (ASCs). Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Get more information on this report : Request Sample Pages

Indication Segment Review

The global implantable cardiac monitors market by indication is segmented into cardiac arrhythmias, atrial fibrillation and epilepsy and unexplained falls. Atrial fibrillation is expected to grow with a high CAGR from 2017-2023. This is attributed to the growing incidence of cardiac arrhythmias and high mortality rate for cardiac diseases including atrial fibrillation.

Get more information on this report : Request Sample Pages

End User Segment Review

The global implantable cardiac monitors market by end user is segmented into hospitals, cardiac centers & clinics and ambulatory surgical centers (ASCs). Cardiac centers & clinics is expected to register a high CAGR during the forecast period. This is due to the advantages offered by cardiac centers & clinics such as reduced stay duration after performing surgical procedures and cardiac centers & clinics offers cost effective treatments for cardiac related ailments.

Get more information on this report : Request Sample Pages

Global Implantable Cardiac Monitors Market by Region

The global implantable cardiac monitors market based on region is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominated the global implantable cardiac monitors market accounting for about two-fifths share of the total market in 2016. This is attributed due to the high adoption rate of technologically advanced implantable cardiac monitors, presence of highly sophisticated healthcare infrastructure and favorable reimbursement framework in North America.

The report provides a comprehensive analysis of the key players operating in the global implantable cardiac monitors market such as Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Edwards Lifescience Corporation, General Electric Company, Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Nihon Kohden Corporation and Phoenix Heart Center. The other players of the global implantable cardiac monitors market include Astellas Pharma, Inc., Sigma-Aldrich Corporation, Agilent Technologies, Inc., ReliantHeart Inc., Abiomed, Inc., Basilea Pharmaceutical Ltd., Berlin Heart GmbH, Schiller AG, and Jarvik Heart, Inc.

Key Benefits

  • The study provides an in-depth analysis of the global implantable cardiac monitors market, with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry, which helps understand the type of products and technologies used globally is included.
  • Key market players and their strategies are provided to understand the competitive outlook of the market.

Implantable Cardiac Monitors Market Key Segments:

By Indication

  • Cardiac Arrhythmias
  • Atrial Fibrillation
  • Epilepsy & Unexplained Falls

By End User

  • Hospitals
  • Cardiac Center & Clinics
  • Ambulatory Surgical Centers (ASCs)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Spain
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Malaysia
    • New Zealand
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Egypt
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2 KEY BENEFITS

1.1.1. Secondary research
1.1.2. Primary research
1.1.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top Winning Strategies

3.2.2.1. Top Winning Strategies, By Year, 2014-2017*
3.2.2.2. Top Winning Strategies, By Development, 2014-2017* (%)
3.2.2.3. Top Winning Strategies, By Company, 2014-2017*

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. MARKET SHARE ANALYSIS, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Extended durability of implantable cardiac monitors
3.5.1.2. Less hospital stay and fewer hospital readmission
3.5.1.3. Rise in incidence of atrial fibrillation, myocardial infraction, and arrhythmias

3.5.2. Restraints

3.5.2.1. Availability of alternative mode of treatment
3.5.2.2. High cost of implantable cardiac monitors

3.5.3. Opportunity

3.5.3.1. Increase in awareness about devices and treatment options for cardiac disorders

Chapter: 4 IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CARDIAC ARRHYTHMIAS

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast by region
4.2.1. Market size and forecast by country

4.3. ATRIAL FIBRILLATION

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast by region
4.3.3. Market size and forecast by country

4.4. EPILEPSY & UNEXPLAINED FALLS

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast by region
4.4.3. Market size and forecast by country

Chapter: 5 IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast by region
5.2.2. Market size and forecast by country

5.3. CARDIAC CENTERS & CLINICS

5.3.1. Market size and forecast by region
5.3.2. Market size and forecast by country

5.4. AMBULATORY SURGICAL CENTERS (ASCS)

5.4.1. Market size and forecast by region
5.4.2. Market size and forecast by country

Chapter: 6 IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends and opportunities
6.2.2. North America market size and forecast, by country
6.2.3. North America market size and forecast, by indication
6.2.4. North America market size and forecast, by end user

6.2.4.1. U.S., market size and forecast by Indication
6.2.4.2. U.S., market size and forecast, by end user
6.2.4.3. Canada market size and forecast, by indication
6.2.4.4. Canada market size and forecast, by end user
6.2.4.5. Mexico market size and forecast, by indication
6.2.4.6. Mexico market size and forecast, by end user

6.3. EUROPE

6.3.1. Key market trends and opportunities
6.3.2. Europe market size and forecast, by country
6.3.3. Europe market size and forecast, by indication
6.3.4. Europe market size and forecast, by end user

6.3.4.1. Germany market size and forecast, by indication
6.3.4.2. Germany market size and forecast, by end user
6.3.4.3. France market size and forecast, by indication
6.3.4.4. France market size and forecast, by end user
6.3.4.5. UK market size and forecast, by indication
6.3.4.6. UK market size and forecast, by end user
6.3.4.7. Italy market size and forecast, by indication
6.3.4.8. Italy market size and forecast, by end user
6.3.4.9. Spain market size and forecast, by indication
6.3.4.10. Spain market size and forecast, by end user
6.3.4.11. Switzerland market size and forecast, by indication
6.3.4.12. Switzerland market size and forecast, by end user
6.3.4.13. Rest of Europe market size and forecast, by indication
6.3.4.14. Rest of Europe market size and forecast, by end user

6.4. ASIA-PACIFIC

6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific market size and forecast, by country
6.4.3. Asia-Pacific market size and forecast, by indication
6.4.4. Asia-Pacific market size and forecast, by end user

6.4.4.1. Japan market size and forecast, by indication
6.4.4.2. Japan market size and forecast, by end user
6.4.4.3. China market size and forecast, by indication
6.4.4.4. China market size and forecast, by end user
6.4.4.5. Australia market size and forecast, by indication
6.4.4.6. Australia market size and forecast, by end user
6.4.4.7. India market size and forecast, by indication
6.4.4.8. India market size and forecast, by end user
6.4.4.9. Malaysia market size and forecast, by indication
6.4.4.10. Malaysia market size and forecast, by end user
6.4.4.11. New Zealand market size and forecast, by indication
6.4.4.12. New Zealand market size and forecast, by end user
6.4.4.13. Rest of Asia-Pacific market size and forecast, by indication
6.4.4.14. Rest of Asia-Pacific market size and forecast, by end user

6.5. LAMEA

6.5.1. Key market trends and opportunities
6.5.2. LAMEA market size and forecast, by country
6.5.3. LAMEA market size and forecast, by indication
6.5.4. LAMEA market size and forecast, by end user

6.5.4.1. Brazil market size and forecast, by indication
6.5.4.2. Brazil market size and forecast, by end user
6.5.4.3. South Africa market size and forecast, by indication
6.5.4.4. South Africa market size and forecast, by end user
6.5.4.5. Egypt market size and forecast, by indication
6.5.4.6. Egypt market size and forecast, by end user
6.5.4.7. Rest of LAMEA market size and forecast, by indication
6.5.4.8. Rest of LAMEA market size and forecast, by end user

Chapter: 7 COMPANY PROFILE

7.1. ABBOTT LABORATORIES

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves and developments

7.2. BIOTRONIK SE & CO. KG

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Key strategic moves and developments

7.3. BOSTON SCIENTIFIC CORPORATION

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance

7.4. EDWARDS LIFE SCIENCE CORPORATION

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance

7.5. GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance

7.6. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance

7.7. LIVANOVA PLC (SORIN)

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance

7.8. MEDTRONIC PLC

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments

7.9. NIHON KOHDEN CORPORATION

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance

7.10. PHOENIX HEART PLLC

7.10.1. Company overview
7.10.2. Operating business segments

LIST OF TABLES

TABLE 1. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 2. IMPLANTABLE CARDIAC MONITOR MARKET FOR CARDIAC ARRHYTHMIAS, BY REGION, 2016-2023 ($MILLION)
TABLE 3. IMPLANTABLE CARDIAC MONITOR MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2016-2023 ($MILLION)
TABLE 4. IMPLANTABLE CARDIAC MONITOR MARKET FOR EPILEPSY & UNEXPLAINED FALLS, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 6. IMPLANTABLE CARDIAC MONITOR MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 7. IMPLANTABLE CARDIAC MONITOR MARKET FOR CARDIAC CENTERS & CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 8. IMPLANTABLE CARDIAC MONITOR MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2016-2023 ($MILLION)
TABLE 9. IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. NORTH AMERICA IMPLANTABLE CARDIAC MONITOR MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 11. NORTH AMERICA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 12. NORTH AMERICA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 13. U.S. IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 14. U.S. IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 15. CANADA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 16. CANADA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 17. MEXICO IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 18. MEXICO IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 19. EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 21. EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 22. GERMANY IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 23. GERMANY IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 24. FRANCE IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 25. FRANCE IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 26. UK IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 27. UK IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 28. ITALY IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 29. ITALY IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 30. SPAIN IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 31. SPAIN IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 32. SWITZERLAND IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 33. SWITZERLAND IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 34. REST OF EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 35. REST OF EUROPE IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 37. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 38. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 39. JAPAN IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 40. JAPAN IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 41. CHINA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 42. CHINA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 43. AUSTRALIA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 44. AUSTRALIA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 45. INDIA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 46. INDIA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 47. MALAYSIA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 48. MALAYSIA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 49. NEW ZEALAND IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 50. NEW ZEALAND IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 51. REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 52. REST OF ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 53. LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 54. LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 55. LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 56. BRAZIL IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 57. BRAZIL IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 58. SOUTH AFRICA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 59. SOUTH AFRICA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 60. EGYPT IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 61. EGYPT IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 62. REST OF LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 63. REST OF LAMEA IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 64. ABBOTT: COMPANY SNAPSHOT
TABLE 65. ABBOTT: OPERATING SEGMENTS
TABLE 66. BIOTRONIK: COMPANY SNAPSHOT
TABLE 67. BIOTRONIK: OPERATING SEGMENTS
TABLE 68. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 69. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 70. EDWARD LIFESCIENCE: COMPANY SNAPSHOT
TABLE 71. EDWARD LIFESCIENCE: OPERATING SEGMENTS
TABLE 72. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 73. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 74. PHILIPS: COMPANY SNAPSHOT
TABLE 75. PHILIPS: OPERATING SEGMENTS
TABLE 76. LIVANOVA: COMPANY SNAPSHOT
TABLE 77. LIVANOVA: OPERATING SEGMENTS
TABLE 78. MEDTRONIC: COMPANY SNAPSHOT
TABLE 79. MEDTRONIC: OPERATING SEGMENTS
TABLE 80. NIHON KOHDEN: COMPANY SNAPSHOT
TABLE 81. NIHON KOHDEN: PRODUCT CATEGORIES
TABLE 82. PHOENIX HEART, PLLC:COMPANY SNAPSHOT
TABLE 83. PHOENIX HEART, PLLC: PRODUCT CATEGORIES

LIST OF FIGURES

FIGURE 1. TOTAL NUMBER OF IMPLANTABLE CARDIAC MONITOR PROCEDURES PERFORMED FROM 2016 TO 2023
FIGURE 2. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, 2016-2023
FIGURE 3. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION, 2016-2023
FIGURE 4. SEGMENTATION OF GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, 2016-2023
FIGURE 5. TOP INVESTMENT POCKETS
FIGURE 6. MODERATE BARGAINING POWER OF BUYERS
FIGURE 7. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 8. HIGH THREAT OF NEW ENTRANTS
FIGURE 9. MODERATE THREAT OF SUBSTITUTION
FIGURE 10. HIGH COMPETITIVE RIVALRY
FIGURE 11. MARKET SHARE ANALYSIS: IMPLANTABLE CARDIAC MONITOR MARKET, 2016
FIGURE 12. KEY DEVELOPMENTS FOR IMPLANTABLE CARDIAC MONITORS BY MEDTRONIC PLC
FIGURE 13. RESTRAINTS AND DRIVERS: GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET
FIGURE 14. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET: BY INDICATION
FIGURE 15. IMPLANTABLE CARDIAC MONITOR MARKET FOR CARDIAC ARRHYTHMIAS, BY COUNTRY, 2016 VS 2023 ($MILLION)
FIGURE 16. IMPLANTABLE CARDIAC MONITOR MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2016 VS 2023 ($MILLION)
FIGURE 17. IMPLANTABLE CARDIAC MONITOR MARKET FOR EPILEPSY & UNEXPLAINED FALLS, BY COUNTRY, 2016 VS 2023 ($MILLION)
FIGURE 18. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER
FIGURE 19. IMPLANTABLE CARDIAC MONITOR MARKET FOR HOSPITALS, BY COUNTRY, 2016 VS 2023 ($MILLION)
FIGURE 20. IMPLANTABLE CARDIAC MONITOR MARKET FOR CARDIAC CENTERS & CLINICS, BY COUNTRY, 2016 VS 2023 ($MILLION)
FIGURE 21. IMPLANTABLE CARDIAC MONITOR MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2016 VS 2023 ($MILLION)
FIGURE 22. IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION
FIGURE 23. ABBOTT: NET SALES, 2014-2016 ($MILLION)
FIGURE 24. ABBOTT: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 25. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 26. BOSTON SCIENTIFIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 27. BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 28. BOSTON SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 29. EDWARD LIFESCIENCE: NET SALES, 2014-2016 ($MILLION)
FIGURE 30. EDWARD LIFESCIENCE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 31. EDWARD LIFESCIENCE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 32. GE HEALTHCARE: REVENUE, 2014-2016 ($MILLION)
FIGURE 33. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 34. GE HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 35. PHILIPS: NET SALES, 2014-2016 ($MILLION)
FIGURE 36. PHILIPS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 37. LIVANOVA: NET SALES, 2014-2016 ($MILLION)
FIGURE 38. LIVANOVA: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 39. LIVANOVA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 40. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)
FIGURE 41. MEDTRONIC: REVENUE BY SEGMENT, 2017 (%)
FIGURE 42. MEDTRONIC: REVENUE BY GEOGRAPHY, 2017 (%)
FIGURE 43. NIHON KOHDEN: NET SALES, 2015-2017 ($MILLION)
FIGURE 44. NIHON KOHDEN: REVENUE BY PRODUCT, 2017 (%)
FIGURE 45. NIHON KOHDEN: REVENUE BY GEOGRAPHY, 2017 (%)

 

Implantable cardiac monitors are devices that continuously monitor the patient’s electrocardiogram and accomplish real-time analysis of the heart rhythm. The battery life of implantable cardiac monitors can last up to three to four years. The utilization of implantable cardiac monitor devices is expected to increase due to the increase in rate of cardiovascular disorders. Remarkable technological advancements have been witnessed in cardiac monitoring devices to provide advanced treatment options for patients suffering from chronic diseases such as cardiac arrthymias, atrial fibrillation, and others. North America is projected to account for the highest revenue, whereas Asia-Pacific region is expected to offer lucrative opportunities to the key players in this market.

Rise in incidence of cardiac disorders, lifestyle changes, technological advancements, increase in patient awareness, and high unmet medical needs in the developing regions are some of the major factors that drive the growth of this market. However, high cost of devices, limited insurance coverage have hampered the market growth. North America is expected to dominate the global market during the forecast period, followed by Europe.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Implantable Cardiac Monitors Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo